iShares Biotechnology ETF Target of Unusually Large Options Trading (NASDAQ:IBB)

iShares Biotechnology ETF (NASDAQ:IBB) saw some unusual options trading on Wednesday. Traders purchased 9,365 put options on the stock. This is an increase of approximately 284% compared to the typical volume of 2,439 put options.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $171.86 on Thursday. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $179.64. The stock has a fifty day moving average of $170.23 and a 200 day moving average of $165.71.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

Institutional Investors Weigh In On iShares Biotechnology ETF

Several large investors have recently added to or reduced their stakes in the business. Dynamic Wealth Strategies LLC boosted its stake in iShares Biotechnology ETF by 16.6% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after buying an additional 60 shares during the period. Flagship Private Wealth LLC lifted its stake in iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after purchasing an additional 60 shares during the last quarter. Larson Financial Group LLC lifted its stake in iShares Biotechnology ETF by 2.3% during the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock worth $458,000 after purchasing an additional 60 shares during the last quarter. Webster Bank N. A. lifted its stake in iShares Biotechnology ETF by 1.0% during the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock worth $1,093,000 after purchasing an additional 62 shares during the last quarter. Finally, Choreo LLC lifted its stake in iShares Biotechnology ETF by 2.2% during the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after purchasing an additional 65 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.